Jemperli plus chemotherapy demonstrated superior overall survival compared to Keytruda in advanced NSCLC, with a median OS of ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...

Finally, the assay can be used with Merck’s Keytruda (pembrolizumab) and GSK’s Jemperli (dostarlimab) across solid tumors ...

GSK has built the case for first-line use of its PD-1 inhibitor Jemperli in endometrial cancer, with new survival data that could help it expand the label for the drug. The latest readout from the ...

GSK’s Jemperli has claimed an edge over its main rival in the endometrial cancer therapy market after showing improved overall survival in a broad patient population in the RUBY trial.

A curated review of what has happened in endometrial cancer research in 2024, including expert commentary, FDA approvals, healthcare disparities, AI, immunotherapies, and more.

MI Cancer Seek has received approval from the FDA as a companion diagnostic test to identify those who may benefit from ...

Mom of 3 was brutally tortured before being set ablaze in Manipur: Autopsy A horrifying incident in Manipur's Jiribam district has left the community reeling after a 31-year-old mother of three ...

Nov. 12, 2024 — The chances of intelligent life emerging in our Universe -- and in any hypothetical ones beyond it -- can be estimated by a new theoretical model ... Nov. 12, 2024 — Scientists ...

Nov. 12, 2024 — Researchers have discovered a remarkable new species of sea slug that lives in the deep sea. Nicknamed the 'mystery mollusc,' the nudibranch Bathydevius caudactylus swims through ...

Investors are assessing whether the post-election rally is about to stall and what Donald Trump's Cabinet picks mean for policy. In a bold projection that's sure to grab attention, veteran Wall ...